Analyst Graham Parry of Bank of America Securities maintained a Buy rating on Sanofi (SNYNF – Research Report), retaining the price ...
Sanofi won approval for the use of a drug combination with its Sarclisa infusion to treat certain types of newly diagnosed ...
J.P. Morgan analyst Richard Vosser maintained a Hold rating on Sanofi (SNYNF – Research Report) today and set a price target of €100.00.
An ambitious project that was hatched during the coronavirus pandemic has hit a key milestone as Sanofi has completed construction of Modulus, a vaccine and biological medicine plant that can be ...
In all, the partners plan to provide enough supply to cover every eligible infant in the U.S. Sanofi has begun shipping the ...
Sanofi said on Friday that its multiple sclerosis drug candidate was shown to delay worsening of a progressive form of the ...
The U.S. Food and Drug Administration said on Friday it has approved the use of a drug combination along with Sanofi's ...
Adult Vaccine Market Adult Vaccine Market Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "Adult Vaccine Market Report, ...
A French pharmaceutical company has been trying to stop a proposed condo development near its Toronto campus by arguing that ...
However, neither DRC nor other African nations produce the vaccines that could slow the spread of mpox and eventually help it ...
The Manila Times on MSN18d
VACC hits Garin for 'lying' on Dengvaxia caseADVOCACY group Volunteers against Crime and Corruption (VACC) on Monday assailed former Health secretary and now Iloilo Rep.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback